Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-28
1995-08-22
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514278, 514397, 514399, 514401, 514438, 514444, 514462, 514632, 514634, 546 15, 5483007, 548407, 549 74, 549 75, 549330, 564227, A61K 31415, C07D40508, C07D40512
Patent
active
054440823
ABSTRACT:
3,9-disubstituted-spiro[5.5]undecanes and ##STR1## wherein, R, Y, A, B and n are defined in the specification, pharmaceutical compositions containing same for the treatment of cardiovascular disorders, such as heart failure and hypertension, are disclosed.
REFERENCES:
patent: 3256277 (1966-06-01), Rice
patent: 3825546 (1974-07-01), Rice
patent: 4098823 (1978-07-01), Arndt
patent: 4737503 (1988-04-01), Sakamoto
patent: 4963557 (1990-10-01), Dadger
patent: 5234922 (1993-08-01), Welsh
Hamer et al "Drugs for heart disease" Chapman & Hall Publisher, pp. 383-385 (1979).
Berger "Medicinal Chemistry" Interscience Publisher, pp. 565-571, 579-581, 600-601 (1960).
Brown, L. & Erdmann, E., "Comparison of the Affinity of Human, Beef and Cat Heart (Na.sup.+ +K.sup.+)-ATPase for for Different Digitalis Derivatives", Arzneim-Forsh., 1984, 34 (II), 1314.
Jorgensen, Peter Leth, "Purification adn Characterization of (Na.sup.+ -K.sup.+)-ATPase III. Purification from the Outer Medulla of Mammalian Kidney After Selective Removal of Membrane Components by Sodium Dodecylsulpate", Biochimica et Biophysica Acta, (1974), pp. 36-51.
Noel, F, and Godfraind, T., "Heterogeneity of Ouabain Specific Binding Sites and (Na++K-.sub.-- -ATPase Inhibition in Microsomes From Rat Heart", Laboratoire de Pharmacodynamie Generale et de Pharmacologie, Universite Catholique de Louvain., Bruxelles, Belgium, Accepted Jul. 12, 1983.
Ferrari Patrizia
Frigerio Marco
Melloni Piero
Salani Giuliana
Chang Ceila
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascul does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascul will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2142155